Victoza (liraglutide), a popular drug used worldwide to treat Type 2 diabetes, has been linked to serious and life-threatening side effects including acute pancreatitis and pancreatic cancer. Medical safety experts are concerned by study findings which show pancreatic problems such as pancreatic cancer and pancreatitis are more common with Victoza than comparable drugs. Given this fact, experts now suggest Victoza risks may outweigh potential benefits of the drug. Victoza puts American patients at risk for pancreatic cancer, and many allege the company knew of the risk and failed to warn consumers.
Victoza is the best-selling product of Novo Nordisk, a leading Danish pharmaceutical company. Victoza was approved in January of 2010, against the recommendation of three FDA safety experts. Victoza dominates the market in its drug class, occupying 72% of the market share and yielded sales of approximately $2 billion in 2014.
Most patients and doctors were unaware of the danger of pancreatic cancer from Victoza. Novo Nordisk, the Danish pharmaceutical company responsible for Victoza, settled a U.S. Department of Justice lawsuit in September of 2017 for $58.65 million over illegal marketing tactics. Eight lawsuits alleged the company violated federal regulations by disguising sales representatives as medical educators who downplayed the importance of FDA Victoza cancer warnings to physicians. Without knowledge of Victoza pancreas risks, patients were unable to make an informed choice about diabetes treatment.
Persons and the family members of persons who have developed pancreas problems such as pancreatitis or pancreatic cancer from Victoza may be eligible to collect real compensation by filing a Victoza lawsuit against Novo Nordisk. Research linking pancreatic cancer to Victoza is available, yet patients and doctors have not been clearly warned. Unfortunately, the threat of Victoza lawsuits for pancreatic cancer may be the only means to pressure Novo Nordisk to take action to safeguard patient safety. Contact our firm today for a free, no-obligation Victoza pancreatic cancer lawsuit case review. Should you choose to retain our Victoza attorneys, there is never any fee unless we win compensation on your behalf.